Hiroaki Kitano

Hiroaki Kitano

Auto-generated profile, based on publicly available information

Hiroaki Kitano

The Systems Biology Institute, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KHKun-Yi Hsin
Kun-Yi Hsin
SGSamik Ghosh
Samik Ghosh
HKHiroaki Kitano
Hiroaki Kitano
Increased availability of bioinformatics resources is creating opportunities for the application of network pharmacology to predict drug effects and toxicity resulting from multi-target interactions. Here we present a high-precision computational prediction approach that combines two elaborately built machine learning systems and multiple molecular docking tools to assess binding potentials of a test compound against proteins involved in a complex molecular network. One of the two machine learning systems is a re-scoring function to evaluate binding modes generated by docking tools. The second is a binding mode selection function to identify the most predictive binding mode. Results from a series of benchmark validations and a case study show that this approach surpasses the prediction reliability of other techniques and that it also identifies either primary or off-targets of kinase inhibitors. Integrating this approach with molecular network maps makes it possible to address drug safety issues by comprehensively investigating network-dependent effects of a drug or drug candidate.

23 February 2007 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
HKHiroaki Kitano
Hiroaki Kitano

1 August 2020 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
SKSarah M Keating
Sarah M Keating
DWDagmar Waltemath
Dagmar Waltemath
Matthias KönigMatthias König
Matthias König
FZFengkai Zhang
Fengkai Zhang
Andreas DrägerAndreas Dräger
Andreas Dräger
MHMichael Hucka
Michael Hucka
Systems biology has experienced dramatic growth in the number, size, and complexity of computational models. To reproduce simulation results and reuse models, researchers must exchange unambiguous model descriptions. We review the latest edition of the Systems Biology Markup Language (SBML), a format designed for this purpose. A community of modelers and software authors developed SBML Level 3 over the past decade. Its modular form consists of a core suited to representing reaction‐based models and packages that extend the core with features suited to other model types including constraint‐based models, reaction‐diffusion models, logical network models, and rule‐based models. The format leverages two decades of SBML and a rich software ecosystem that transformed how systems biologists build and interact with models. More recently, the rise of multiscale models of whole cells and organs, and new data sources such as single‐cell measurements and live imaging, has precipitated new ways of integrating data with models. We provide our perspectives on the challenges presented by these developments and how SBML Level 3 provides the foundation needed to support this evolution.

21 December 2010 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
ECEtienne Caron
Etienne Caron
SGSamik Ghosh
Samik Ghosh
YMYukiko Matsuoka
Yukiko Matsuoka
DADariel Ashton‐Beaucage
Dariel Ashton‐Beaucage
MTMarc Therrien
Marc Therrien
HKHiroaki Kitano
Hiroaki Kitano
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

29 April 2016 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
KHKun-Yi Hsin
Kun-Yi Hsin
YMYukiko Matsuoka
Yukiko Matsuoka
YAYoshiyuki Asai
Yoshiyuki Asai
KKKyota Kamiyoshi
Kyota Kamiyoshi
TWTokiko Watanabe
Tokiko Watanabe
HKHiroaki Kitano
Hiroaki Kitano
We present systemsDock, a web server for network pharmacology-based prediction and analysis, which permits docking simulation and molecular pathway map for comprehensive characterization of ligand selectivity and interpretation of ligand action on a complex molecular network. It incorporates an elaborately designed scoring function for molecular docking to assess protein–ligand binding potential. For large-scale screening and ease of investigation, systemsDock has a user-friendly GUI interface for molecule preparation, parameter specification and result inspection. Ligand binding potentials against individual proteins can be directly displayed on an uploaded molecular interaction map, allowing users to systemically investigate network-dependent effects of a drug or drug candidate. A case study is given to demonstrate how systemsDock can be used to discover a test compound's multi-target activity. systemsDock is freely accessible at http://systemsdock.unit.oist.jp/.

18 June 2021 in npj Systems Biology and Applications
Verified
Journal Article
Open access
PDF file
HKHiroaki Kitano
Hiroaki Kitano
Scientific discovery has long been one of the central driving forces in our civilization. It uncovered the principles of the world we live in, and enabled us to invent new technologies reshaping our society, cure diseases, explore unknown new frontiers, and hopefully lead us to build a sustainable society. Accelerating the speed of scientific discovery is therefore one of the most important endeavors. This requires an in-depth understanding of not only the subject areas but also the nature of scientific discoveries themselves. In other words, the “science of science” needs to be established, and has to be implemented using artificial intelligence (AI) systems to be practically executable. At the same time, what may be implemented by “AI Scientists” may not resemble the scientific process conducted by human scientist. It may be an alternative form of science that will break the limitation of current scientific practice largely hampered by human cognitive limitation and sociological constraints. It could give rise to a human-AI hybrid form of science that shall bring systems biology and other sciences into the next stage. The Nobel Turing Challenge aims to develop a highly autonomous AI system that can perform top-level science, indistinguishable from the quality of that performed by the best human scientists, where some of the discoveries may be worthy of Nobel Prize level recognition and beyond.